This project used vapor phase infrared spectroscopy to differentiate isomeric methoxybenzyl-NBOMes.
The common NBOMe drugs of abuse, N-(2-methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine (25I-NBOMe) and N-(2-methoxybenzyl)-4-bromo-2,5-dimethoxyphenethylamine (25B-NBOMe), can be differentiated from their corresponding 3- and 4-methoxybenzyl isomers by gas chromatography with vapor phase infrared spectroscopy. The mass spectra for these regioisomeric compounds are essentially identical providing only the identity of the halogen but no specific ions to identify the methoxy group position on the benzyl aromatic ring. The bands from single ring model compounds 2C-B, 2C-I, and all three positional methoxy substituted benzylamines were used to assign each vapor phase absorption band to either the halogenated 2,5 dimethoxybenzene ring or the methoxybenzylamine ring. A pair of aromatic ring stretching bands reflect the position of methoxy group substitution on the benzyl aromatic ring. The 1608 cm−1 band is specific for the two regioisomeric 4-methoxy-benzylamine isomers and this band occurs at 1593 cm−1 for the 2-methoxy isomer in both the 25I and 25B series and shifts to1597/1598 cm−1 for 3-methoxybenzyl 25I and 25B. Asymmetric aryl-O stretching frequencies shift with a change in methoxy substitution around the benzyl aromatic ring (Ring 2) and occur at 1237/1238 cm−1 for ortho, 1261 cm−1 for meta, and 1246 cm−1 for the para isomers. The overall shape and relative intensities of numerous bands in the vapor phase spectra provide clear identification for the individual methoxybenzyl isomers for the 25I-NBOMe and 25B-NBOMe series. (publisher abstract modified)
- Prevalence and determinants of safety equipment use: Analysis from a national dataset of law enforcement officers in the US
- Traumatic brain injury and mental health outcomes among recently incarcerated men
- Revalidation of the First Step Act Risk Assessment: A Test of Predictive Strength, Dynamic Validity, and Racial/Ethnic Neutrality